清肺排毒汤治疗新型冠状病毒肺炎的疗效和安全性:系统评价和meta分析

Zhenyou Yang, Shuo Zhang, Yujia Tang, Sai Zhang, S. Yue, Qi-Ling Liu
{"title":"清肺排毒汤治疗新型冠状病毒肺炎的疗效和安全性:系统评价和meta分析","authors":"Zhenyou Yang, Shuo Zhang, Yujia Tang, Sai Zhang, S. Yue, Qi-Ling Liu","doi":"10.53043/2347-3894.acam90024","DOIUrl":null,"url":null,"abstract":"Backgrounds: Since the outbreak of new coronavirus pneumonia worldwide, there are no specific drugs up to now. In people’s struggle with the disease, more and more clinical practice shows that traditional Chinese medicine has shown an increasingly important role in the outbreak. Among them, Qingfei Paidu decoction (QFPD) has been widely used in China and overseas Chinese, which has good advantages in the treatment of COVID-19. Although some meta-analyses have studied the efficacy of QFPD in the treatment of COVID-19, the inclusion and exclusion criteria of trials in these studies were not strict enough and their results were not consistent. So, the exact efficacy of QFPD for treating COVID-19 was still questionable. Objective: To systematically evaluate the efficacy and safety of QFPD for COVID-19. Methods: A comprehensive literature search of qualified trials using QFPD to treat COVID-19 was conducted in 11 electronic databases, including Medline, Embase, Cochrane Library, PubMed, Web of Science, Springer link, Clinicaltrials.gov, etc. From their establishment to March 1, 2021. Subjects and abstracts of the trials were read in Note Express for preliminary screening, and the full text was read for further screening. Researchers independently extracted the data in duplicate, and the risk of bias of trials was assessed by using the Cochrane collaboration tool, followed by data analysis using Rev Man 5.3. Results: Four trials with 390 participants were included for meta-analysis, revealing that QFPD can effectively shorten the average length of stay in hospital and the time of nucleic acid to turn negative. In terms of adverse reactions, there was no significant difference between the experimental and control groups. Conclusions: These results demonstrated that QFPD could effectively treat COVID-19, improve clinical symptoms, shorten hospital stay and nucleic acid negative time, and no obvious adverse reactions have been found. Compared with other meta-analyses of QFPD, this research has some unique features, including its comprehensiveness, the large-scale of its search and its transparent approach, which may provide some new treatment ideas for clinicians. Keywords: Qingfei Paidu decoction; COVID-19; 2019-NcoV; Systematic review; Meta-analysis","PeriodicalId":72312,"journal":{"name":"Asian journal of complementary and alternative medicine : A-CAM","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Efficacy and Safety of Qingfei Paidu Decoction for Patients with COVID-19: A Systematic Review and Meta-Analysis\",\"authors\":\"Zhenyou Yang, Shuo Zhang, Yujia Tang, Sai Zhang, S. Yue, Qi-Ling Liu\",\"doi\":\"10.53043/2347-3894.acam90024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Backgrounds: Since the outbreak of new coronavirus pneumonia worldwide, there are no specific drugs up to now. In people’s struggle with the disease, more and more clinical practice shows that traditional Chinese medicine has shown an increasingly important role in the outbreak. Among them, Qingfei Paidu decoction (QFPD) has been widely used in China and overseas Chinese, which has good advantages in the treatment of COVID-19. Although some meta-analyses have studied the efficacy of QFPD in the treatment of COVID-19, the inclusion and exclusion criteria of trials in these studies were not strict enough and their results were not consistent. So, the exact efficacy of QFPD for treating COVID-19 was still questionable. Objective: To systematically evaluate the efficacy and safety of QFPD for COVID-19. Methods: A comprehensive literature search of qualified trials using QFPD to treat COVID-19 was conducted in 11 electronic databases, including Medline, Embase, Cochrane Library, PubMed, Web of Science, Springer link, Clinicaltrials.gov, etc. From their establishment to March 1, 2021. Subjects and abstracts of the trials were read in Note Express for preliminary screening, and the full text was read for further screening. Researchers independently extracted the data in duplicate, and the risk of bias of trials was assessed by using the Cochrane collaboration tool, followed by data analysis using Rev Man 5.3. Results: Four trials with 390 participants were included for meta-analysis, revealing that QFPD can effectively shorten the average length of stay in hospital and the time of nucleic acid to turn negative. In terms of adverse reactions, there was no significant difference between the experimental and control groups. Conclusions: These results demonstrated that QFPD could effectively treat COVID-19, improve clinical symptoms, shorten hospital stay and nucleic acid negative time, and no obvious adverse reactions have been found. Compared with other meta-analyses of QFPD, this research has some unique features, including its comprehensiveness, the large-scale of its search and its transparent approach, which may provide some new treatment ideas for clinicians. Keywords: Qingfei Paidu decoction; COVID-19; 2019-NcoV; Systematic review; Meta-analysis\",\"PeriodicalId\":72312,\"journal\":{\"name\":\"Asian journal of complementary and alternative medicine : A-CAM\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Asian journal of complementary and alternative medicine : A-CAM\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.53043/2347-3894.acam90024\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian journal of complementary and alternative medicine : A-CAM","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53043/2347-3894.acam90024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

背景:新型冠状病毒肺炎疫情在全球范围内爆发以来,至今尚无特效药。在人们与疾病的斗争中,越来越多的临床实践表明,中医药在疫情中发挥着越来越重要的作用。其中清肺排毒汤已在国内外广泛应用,在治疗新冠肺炎方面具有良好优势。尽管一些荟萃分析研究了QFPD治疗新冠肺炎的疗效,但这些研究中试验的纳入和排除标准不够严格,结果也不一致。因此,QFPD治疗新冠肺炎的确切疗效仍然值得怀疑。目的:系统评价QFPD治疗新冠肺炎的疗效和安全性。方法:从建立到2021年3月1日,在Medline、Embase、Cochrane Library、PubMed、Web of Science、Springer link、Clinicaltrials.gov等11个电子数据库中对QFPD治疗新冠肺炎的合格试验进行全面文献检索。受试者和试验摘要在Note Express中阅读以进行初步筛选,全文阅读以进行进一步筛选。研究人员独立提取了一式两份的数据,并使用Cochrane协作工具评估了试验偏倚的风险,然后使用Rev Man 5.3进行数据分析。结果:纳入了4项试验,共390名参与者进行荟萃分析,结果表明QFPD可以有效缩短平均住院时间和核酸转阴时间。在不良反应方面,实验组和对照组之间没有显著差异。结论:QFPD能有效治疗新冠肺炎,改善临床症状,缩短住院时间和核酸阴性时间,未见明显不良反应。与其他QFPD的荟萃分析相比,本研究具有一些独特的特点,包括其全面性、大规模的搜索和透明的方法,这可能为临床医生提供一些新的治疗思路。关键词:清肺排毒汤;2019冠状病毒疾病2019新型冠状病毒系统评审;Meta分析
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Efficacy and Safety of Qingfei Paidu Decoction for Patients with COVID-19: A Systematic Review and Meta-Analysis
Backgrounds: Since the outbreak of new coronavirus pneumonia worldwide, there are no specific drugs up to now. In people’s struggle with the disease, more and more clinical practice shows that traditional Chinese medicine has shown an increasingly important role in the outbreak. Among them, Qingfei Paidu decoction (QFPD) has been widely used in China and overseas Chinese, which has good advantages in the treatment of COVID-19. Although some meta-analyses have studied the efficacy of QFPD in the treatment of COVID-19, the inclusion and exclusion criteria of trials in these studies were not strict enough and their results were not consistent. So, the exact efficacy of QFPD for treating COVID-19 was still questionable. Objective: To systematically evaluate the efficacy and safety of QFPD for COVID-19. Methods: A comprehensive literature search of qualified trials using QFPD to treat COVID-19 was conducted in 11 electronic databases, including Medline, Embase, Cochrane Library, PubMed, Web of Science, Springer link, Clinicaltrials.gov, etc. From their establishment to March 1, 2021. Subjects and abstracts of the trials were read in Note Express for preliminary screening, and the full text was read for further screening. Researchers independently extracted the data in duplicate, and the risk of bias of trials was assessed by using the Cochrane collaboration tool, followed by data analysis using Rev Man 5.3. Results: Four trials with 390 participants were included for meta-analysis, revealing that QFPD can effectively shorten the average length of stay in hospital and the time of nucleic acid to turn negative. In terms of adverse reactions, there was no significant difference between the experimental and control groups. Conclusions: These results demonstrated that QFPD could effectively treat COVID-19, improve clinical symptoms, shorten hospital stay and nucleic acid negative time, and no obvious adverse reactions have been found. Compared with other meta-analyses of QFPD, this research has some unique features, including its comprehensiveness, the large-scale of its search and its transparent approach, which may provide some new treatment ideas for clinicians. Keywords: Qingfei Paidu decoction; COVID-19; 2019-NcoV; Systematic review; Meta-analysis
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
SFI Reduces the Nucleocytoplasmic Transportation of HMGB1 by Upregulating HDAC3 in LPS-induced RAW264.7 Cells Magnesium – The Metabolic Blockbuster The Controversy: Whether Sucralose Could Increase Blood Glucose in The Body? Rare Clinical Conditions Caused by Dry Eye Bioinformatics-based Prediction of Character of Envelope Glycoprotein and Analysis of Epitopes of B- and T-cell of gp120
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1